Evoke Pharma Inc (EVOK)

Nov 26, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion (2024-2028), Diabetes Burden Boosts Growth, AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Nov 26, 2024

Nov 21, 2024

Mesenchymal Stem Cells (MSC) Market Set to Surpass USD 9.72 - GlobeNewswire

Nov 21, 2024

Nov 20, 2024

Diabetic Gastroparesis Pipeline 2024: Clinical Trials - openPR

Nov 20, 2024

Nov 16, 2024

EVOK (Evoke Pharma) Total Assets : $14.15 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024

Nov 15, 2024

Diabetic Gastroparesis Treatment Market: Global Size, Share, - openPR

Nov 15, 2024

Nov 14, 2024

Altium Capital Management LP Increases Stake in Evoke Pharma Inc - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Nasal Drug Delivery Technology Market Breakthrough in Patient Care, Projected Market Growth to USD 7.8 Billion by 2031Market Research Intellect - The Malaysian Reserve

Nov 12, 2024

Nov 12, 2024

By popular demand: SiGMA Europe launches fourth shed - GlobeNewswire Inc.

Nov 12, 2024

Nov 12, 2024

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 12, 2024

Nov 10, 2024

Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 10, 2024

Nov 08, 2024

Evoke Pharma earnings missed by $0.95, revenue fell short of estimates - Investing.com UK

Nov 08, 2024

Nov 08, 2024

(EVOK) Trading Advice - Stock Traders Daily

Nov 08, 2024

Nov 08, 2024

BlackLine Announces the Planned Retirement of Chief Financial Officer and Names Successor - The Manila Times

Nov 08, 2024

Nov 08, 2024

Evoke Pharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Canopy Growth (CGC) Stock Surges 5.2% Amid Industry Movement - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 07, 2024

Nov 07, 2024

Nantahala Capital Management's Strategic Acquisition in Evoke Ph - GuruFocus.com

Nov 07, 2024

Nov 06, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 06, 2024

Nov 05, 2024

Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now? - Yahoo Canada Finance

Nov 04, 2024

Nov 04, 2024

Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit - Yahoo Finance

Nov 04, 2024

Nov 04, 2024

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Nov 04, 2024

Nov 03, 2024

Global Digestive Health Market Size, Share And Growth Analysis For 2024-2033 - EIN News

Nov 03, 2024

Nov 01, 2024

Canopy Growth Corporation (CGC) Stock Price, News, Quote & History - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Evoke Pharma (FRA:EV0) Enterprise Value : €1.02 Mil (As of Nov. 01, 2024) - GuruFocus.com

Nov 01, 2024

Oct 30, 2024

Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR

Oct 30, 2024

Oct 29, 2024

When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Become Profitable? - Simply Wall St

Oct 29, 2024

Oct 29, 2024

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 29, 2024

Oct 29, 2024

Five things for pharma marketers to know for Tuesday morning - MM+M Online

Oct 29, 2024

Oct 28, 2024

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings - MSN

Oct 28, 2024

Oct 28, 2024

Evoke Pharma holds Buy rating with $18 target from Laidlaw - Investing.com

Oct 28, 2024

Oct 28, 2024

Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart

Oct 28, 2024

Oct 28, 2024

EVOK Stock Earnings: Evoke Pharma Misses EPS, Misses Revenue for Q2 2024 - MSN

Oct 28, 2024

Oct 28, 2024

Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis - Yahoo Finance

Oct 28, 2024

Oct 28, 2024

What made Evoke Pharma stock more than double on Monday? - Invezz

Oct 28, 2024

Oct 28, 2024

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga

Oct 28, 2024

Oct 28, 2024

Evoke Pharma Shares Rise 70% on Gimoti Data in GLP-1 Users - MarketWatch

Oct 28, 2024

Oct 28, 2024

Evoke stock rockets 90% on study of Gimoti in GLP-1 users (NASDAQ:EVOK) - Seeking Alpha

Oct 28, 2024

Oct 28, 2024

Dow Jumps Over 300 Points; ON Semiconductor Earnings Top ViewsHealthcare Triangle (NASDAQ:HCTI) - Benzinga

Oct 28, 2024

Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024

Oct 28, 2024

Evoke Pharma Stock Is Soaring Monday: What's Going On? - Benzinga

Oct 28, 2024

Oct 28, 2024

Evoke Pharma reports significant benefits of GIMOTI in DGP study - Investing.com India

Oct 28, 2024

Oct 28, 2024

Evoke Pharma & EVERSANA Announce Statistically Significant - GlobeNewswire

Oct 28, 2024

Oct 28, 2024

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI® - StockTitan

Oct 28, 2024